Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Actuate Therapeutics Inc Is A Clinical Stage Biopharmaceutical Company Focused On Developing Therapies For The Treatment Of High Impact, Difficult To Treat Cancers Through The Inhibition Of Glycogen Synthase Kinase-3 (Gsk-3). It Is Developing Elraglusib (Formerly 9-Ing-41), A Small Molecule That Is Designed To Enter Cancer Cells And Block The Function Of The Enzyme Gsk-3b, A Master Regulator Of Complex Biological Signaling Cascades, Including Those Mediated By Oncogenes, That Lead To Tumor Cell Survival, Growth, Migration, And Invasion.